Physician

Jacob Anthony Vella, MD

According to 2025 Medicare claims, Jacob Vella, MD (NPI: 1467603670) practices interventional pain management (ipm) in the Montgomery, AL market, with the plurality of this provider's patient population coming from Montgomery, AL. This provider's primary affiliated billing organization is THE CENTER FOR PAIN OF MONTGOMERY LLC (NPI: 1588710289; TIN: 721374394) and primary practice location at 36116-2462.

Vella's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 589 traditional Medicare patients, billed 59,059 HCPCS/CPT codes, and received $665,189 in Medicare payments. The top billing code was G0481 (Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms). Part D data shows 25,429 prescription claims across 1,981 beneficiaries totaling $753,758 in drug costs, led by Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen). 2016 DME data shows 35 claims. Open Payments data shows 110 records totaling $11,779. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $187,178 to $665,189. Similarly, Part D prescription costs have moved sharply higher in recent years, from $21,903 to $753,758. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$367K$734K2015 Medicare payment: $187,178 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $154,755 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $183,866 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $193,098 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $697,850 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $636,079 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $734,369 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $612,401 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $686,871 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $665,189 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20156023,037$187,178
20167381,970$154,755
20178082,237$183,866
20188333,643$193,098
201990914,124$697,850
202069111,015$636,079
202177712,781$734,369
202269917,158$612,401
202359411,751$686,871
202458959,059$665,189

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$487K$975K2015 Drug cost: $21,903 (USD; Tot_Drug_Cst)2016 Drug cost: $5,570 (USD; Tot_Drug_Cst)2017 Drug cost: $10,244 (USD; Tot_Drug_Cst)2018 Drug cost: $28,828 (USD; Tot_Drug_Cst)2019 Drug cost: $314,243 (USD; Tot_Drug_Cst)2020 Drug cost: $352,065 (USD; Tot_Drug_Cst)2021 Drug cost: $593,378 (USD; Tot_Drug_Cst)2022 Drug cost: $840,479 (USD; Tot_Drug_Cst)2023 Drug cost: $974,669 (USD; Tot_Drug_Cst)2024 Drug cost: $753,758 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201563161$21,903
20165594$5,570
201776117$10,244
2018215432$28,828
20191,1527,156$314,243
20201,11911,348$352,065
20211,33214,452$593,378
20221,56718,870$840,479
20231,62222,522$974,669
20241,98125,429$753,758

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$1.1K$2.1K2015 Medicare payment: $444 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $2,136 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
20151415$444
20163035$2,136
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
G0481Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms304587$153
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more4251,836$86
80307Testing for presence of drug, by chemistry analyzers333670$58
J2250Injection, midazolam hydrochloride, per 1 mg2401,650$0
J1010Injection, methylprednisolone acetate, 1 mg27946,135$0

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen4,039115,113$122,879
RelistorMethylnaltrexone Bromide391,150$91,147
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen4,758132,091$83,362
MovantikNaloxegol Oxalate1143,478$47,624
PregabalinPregabalin2,51576,441$41,119

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.110$11,779Abbott Laboratories
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jacob Anthony Vella, MD?

Tedicare shows public-source Medicare data for Jacob Anthony Vella, MD (NPI 1467603670), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jacob Anthony Vella, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jacob Anthony Vella, MD?

Jacob Anthony Vella, MD is linked to THE CENTER FOR PAIN OF MONTGOMERY LLC (billing NPI 1588710289) in the available physician profile data.

Does Jacob Anthony Vella, MD have Open Payments data?

Jacob Anthony Vella, MD has 110 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.